Válvula Aórtica

Structural heart disease

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of...

Dr. Andrés Rodríguez - 11 February, 2026

Learn More

Structural heart disease

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in...

Dr. Juan Manuel Pérez - 10 February, 2026

Learn More

Structural heart disease

New Balloon-Expandable Aortic Valve: 30-Day Outcomes in Patients with Small Aortic Annulus

As transcatheter aortic valve implantation (TAVI) continues to expand toward younger patients with longer life expectancy, factors...

Dr. Andrés Rodríguez - 10 February, 2026

Learn More

Structural heart disease

TAVI in small aortic annulus: self-expanding or balloon-expandable valve in the long term?

Patients with a small aortic annulus (a predominantly female population with a higher risk of prosthesis–patient mismatch)...

Dr. Juan Manuel Pérez - 5 February, 2026

Learn More

Structural heart disease

Long-Term Predictors of Valve Deterioration After TAVI

Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe...

Dr. Andrés Rodríguez - 30 January, 2026

Learn More

Structural heart disease

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance...

Dr. Juan Manuel Pérez - 29 January, 2026

Learn More

Structural heart disease

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in...

Dr. Omar Tupayachi - 21 January, 2026

Learn More

Pharmacology

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block...

Dr. Juan Manuel Pérez - 15 January, 2026

Learn More

Válvula Aórtica

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

New Balloon-Expandable Aortic Valve: 30-Day Outcomes in Patients with Small Aortic Annulus

TAVI in small aortic annulus: self-expanding or balloon-expandable valve in the long term?

Long-Term Predictors of Valve Deterioration After TAVI

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Is it safe to use negative chronotropic drugs early after TAVI?

Last News

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Institutional News

Fellow’s Corner 2026 – Submit Your Clinical Case

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

Access